MarketPulse

neurostimulation

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Brainsway Ltd.

BrainsWay Sets Q1 2026 Earnings Call for May 13 Amid Growing TMS Payer Support

BrainsWay will report Q1 2026 results May 13, highlighting expanding U.S. payer coverage for nurse practitioner-administered TMS therapy.
BWAYDeep TMSneurostimulation
GlobeNewswire Inc.GlobeNewswire Inc.··Nexalin Technology, Inc.

Nexalin's Brain Stimulation Tech Shows Promise for Teen Depression, Self-Injury

Nexalin's DIFS neurostimulation technology reduced self-injury and depression symptoms in female adolescents, per peer-reviewed study published in BMC Psychiatry.
NXLclinical trialneurostimulation
GlobeNewswire Inc.GlobeNewswire Inc.··Brainsway Ltd.

BrainsWay Sets March 11 Date for 2025 Full-Year Results and Earnings Call

BrainsWay will release 2025 full-year financial results on March 11, 2026, followed by an 8:30 AM ET earnings call to discuss performance and operational updates.
BWAYfinancial resultsconference call